Cargando…
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
CpG island arrays represent a high-throughput epigenomic discovery platform to identify global disease-specific promoter hypermethylation candidates along bladder cancer progression. DNA obtained from 10 pairs of invasive bladder tumours were profiled vs their respective normal urothelium using diff...
Autores principales: | Aleman, A, Adrien, L, Lopez-Serra, L, Cordon-Cardo, C, Esteller, M, Belbin, T J, Sanchez-Carbayo, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361432/ https://www.ncbi.nlm.nih.gov/pubmed/18087279 http://dx.doi.org/10.1038/sj.bjc.6604143 |
Ejemplares similares
-
MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9
por: Jia, A Y, et al.
Publicado: (2014) -
Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis
por: Manton, K J, et al.
Publicado: (2005) -
Somatostatin Receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer
por: Zhao, J, et al.
Publicado: (2013) -
CpG-island methylation study of liver fluke-related cholangiocarcinoma
por: Sriraksa, R, et al.
Publicado: (2011) -
Promoter CpG methylation in cancer cells contributes to the regulation of MUC4
por: Yamada, N, et al.
Publicado: (2009)